Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5071-5080 of 11715

Edit search filters
  1. A Study Of LensOne Prosthetic Capsule In Aphakic Patients Lacking Capsular Support

    Rochester, MN

  2. K-5475-013 INSIGNIA-PH-COPD: A Study Of The Efficacy And Safety Of MK-5475 (An Inhaled SGC Stimulator) In Adults With PH-COPD

    Rochester, MN

  3. A Phase 2, Open-Label Study Of DISC-3405 In Participants With Polycythemia Vera (PV)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

    Eau Claire, WI, Jacksonville, FL, Rochester, MN

  5. Rituximab With Or Without Stem Cell Transplant In Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma In First Complete Remission

    Jacksonville, FL, Rochester, MN

  6. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate DS-8201a Combined With Olaparib In HER2-Expressing Cancers With Expansion In Endometrial Cancer Patients Testing The Combination Of DS-8201a And Olaparib In HER2-Expressing Cancers With Expansion In Patients With Endometrial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study Of Intratumoral Injection Of Autologous Dendritic Cells After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Liver Cancer

    Rochester, MN

  9. Health Coaching to Improve Self-Management in Thoracic Transplant Candidates

    Rochester, MN

  10. A Study To Investigate Ubamatamab With And Without REGN7075 In Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer